IL17RD and neoplasm: Intriguingly, a recent study reported that shRNA-mediated depletion of IL-17RD in the mouse epithelial-like lung carcinoma cell line 393P, which modestly slows down proliferation, markedly reduces in vivo tumor growth and sensitizes tumors to a MEK1/2 inhibitor (24).